Contineum Therapeutics, Inc. ($CTNM)
Filing Information
| Accession Number | 0001437749-26-003212 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 3, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
4,170
Total Value
$62,305.47
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Class A Common Stock | โ | Feb 3, 2026 | Sale | 3,000 | $14.82 | $44,468.70 | 157,222 | Direct | โ | View Details | |
Chief Scientific Officer | Class A Common Stock | โ | Feb 3, 2026 | Sale | 1,170 | $15.25 | $17,836.77 | 156,052 | Direct | โ | View Details |